Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-01-25

Clinical Trial Update: A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Nexium (esomeprazole) to ranitidine for healing NSAID-associated gastric ulcers in patients continuing daily NSAID use; the study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nexium (esomeprazole)
  • Zantac (ranitidine)

Snippet

Sponsor: AstraZeneca | Conditions: NSAID Associated Gastric Ulcers | Phase 3 | Status: COMPLETED